{"Name":"Familial hyperaldosteronism type II","DiseaseID__c":"GARD:0002789","id":2789,"encodedName":"familial-hyperaldosteronism-type-ii","IsDeleted":false,"Disease_Name_Full__c":"Familial hyperaldosteronism type II","Xref_IDs__c":"703233008; C127162; C1854107; C565312; MEDGEN:340137; MONDO:0011576; OMIM:605635; ORPHA:404","USA_Estimate__c":null,"No_of_Specialist_Tagsa__c":4,"No_of_ClinGen_records__c":0,"No_of_GeneReviews__c":0,"No_of_HHS_records__c":0,"World_Estimate__c":null,"No_of_HRSA_records__c":0,"Evidence_Based_Score__c":0,"No_of_Disease_Descriptions__c":3,"Disease_Characteristics_Score__c":8,"No_of_Age_at_Onset__c":1,"Description_Source__c":"MONDO:0011576","Disease_Description__c":"A heritable form of primary aldosteronism (PA) characterized by hypertension of varying severity, non-glucocorticoid remediable hyperaldosteronism, variable hypokalemia, low plasma renin activity (PRA) and increased aldosterone-to-renin ratio.","GARD_Name__c":"Familial hyperaldosteronism type II","GARD_Synonym__c":"familial adrenal adenoma; familial hyperaldosteronism type 2; fh ii; fh-ii; fh2","Curated_Disease_Description_Source__c":"MONDO:0011576","Curated_Disease_Description__c":"A heritable form of primary aldosteronism (PA) characterized by hypertension of varying severity, non-glucocorticoid remediable hyperaldosteronism, variable hypokalemia, low plasma renin activity (PRA) and increased aldosterone-to-renin ratio.","Curated_USA_Estimate_Source__c":null,"Curated_USA_Estimate__c":null,"Age_at_Onset_Snippet_Text__c":"as an Adult","SourceID__c":"ORPHA:404","Deprecated__c":"No","Disease_Concept_Type__c":"Rare Disease Entity","MONDO_ID__c":"MONDO:0011576","ORPHANET_ID__c":"ORPHA:404","Replaced_By_ID__c":null,"Display_Spanish_Disease_Name__c":"Hiperaldosteronismo familiar tipo ii","Spanish_Description_Source__c":"ORPHA:404","Spanish_Description__c":"Es una forma hereditaria de aldosteronismo primario (AP) caracterizada por hipertensión de gravedad variable, hiperaldosteronismo sin respuesta al tratamiento con glucocorticoides, hipopotasemia variable, baja actividad de la renina plasmática (ARP) y aumento de la proporción de aldosterona a renina.","Spanish_Disease_Name__c":"hiperaldosteronismo familiar tipo ii","Spanish_GARD_Synonym__c":"fh-ii; fh2; hiperaldosteronismo familiar tipo 2","Category_Linearization__c":"ORPHA:97978","icd10_id__c":null,"mesh_id__c":null,"omim_id__c":null,"snomed_id__c":null,"umls_id__c":null,"GARD_Disease__c":[{"Curated_Disease_Description__c":"A heritable form of primary aldosteronism (PA) characterized by hypertension of varying severity, non-glucocorticoid remediable hyperaldosteronism, variable hypokalemia, low plasma renin activity (PRA) and increased aldosterone-to-renin ratio.","Curated_Disease_Description_Source__c":"MONDO:0011576","GARD_Synonym__c":"familial adrenal adenoma; familial hyperaldosteronism type 2; fh ii; fh-ii; fh2","Name":"Familial hyperaldosteronism type II","estimateUsa":""}],"Organization_Supported_Diseases__c":[{"Account_Name__c":"Primary Aldosteronism Foundation","Website__c":"https://www.primaryaldosteronism.org/"}],"GARD_Disease_Tag__c":[{"Tag_Name__c":"Cancer - Oncologist","Tag_Category__c":"Specialist"},{"Tag_Name__c":"Cancer","Tag_Category__c":"Disease Category","category_description":"Cancer is a disease in which some of the body's cells grow uncontrollably and can spread to other parts of the body.","curated_tag_name":"Cancer"},{"Tag_Name__c":"Genetics","Tag_Category__c":"Cause;Disease Category;Specialist","category_description":"Genetic diseases affect the DNA, or genetic instructions, which directs how tissues, organs, and body systems function.","curated_tag_name":"Genetic diseases"},{"Tag_Name__c":"Nephrology","Tag_Category__c":"Account;Disease Category;Specialist","category_description":"Kidney diseases affect the kidneys' ability to remove waste and water from blood, create urine, or make certain hormones.","curated_tag_name":"Kidney diseases"},{"Tag_Name__c":"Endocrine","Tag_Category__c":"Disease Category;Specialist","category_description":"Endocrine diseases affect hormone production or how the body responds to a specific hormone(s).","curated_tag_name":"Endocrine diseases"}],"Age_At_Onset__c":[{"Age_At_Onset__c":"Adult","Provided_By__c":"ORPHA:404"}],"Diagnosis__c":[{"Type__c":"GTR","Curie__c":"MEDGEN:C1854107"}],"External_Identifier_Disease__c":[{"URL__c":"https://raresource.nih.gov/diseases/filter/0002789","Source__c":"RareSource"},{"URL__c":"https://uts.nlm.nih.gov/uts/umls/concept/C1854107","Source__c":"C1854107","Xref__c":"C1854107"},{"URL__c":"https://www.omim.org/entry/605635","Source__c":"C1854107; MONDO:0011576; ORPHA:404","Xref__c":"OMIM:605635"},{"URL__c":"https://browser.ihtsdotools.org/?perspective=full&conceptId1=703233008","Source__c":"C1854107; MONDO:0011576","Xref__c":"703233008"},{"URL__c":"https://www.ncbi.nlm.nih.gov/mesh/C565312","Source__c":"MONDO:0011576","Xref__c":"C565312"},{"URL__c":"https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C127162","Source__c":"C1854107; MONDO:0011576","Xref__c":"C127162"},{"URL__c":"https://www.orpha.net/en/disease/detail/404","Source__c":"C1854107; MONDO:0011576; ORPHA:404","Xref__c":"ORPHA:404"},{"URL__c":"https://www.ncbi.nlm.nih.gov/medgen/?term=340137","Source__c":"C1854107","Xref__c":"MEDGEN:340137"},{"URL__c":"http://purl.obolibrary.org/obo/MONDO_0011576","Source__c":"GARD:0002789","Xref__c":"MONDO:0011576"}],"GARD_Disease_Gene__c":[{"GeneSymbol__c":"CLCN2","GHR_URL__c":"https://medlineplus.gov/genetics/gene/clcn2","Gene_Type__c":"protein-coding gene","Causal_Gene__c":true}],"Inheritance__c":["Autosomal dominant"],"GARD_Disease_Feature__c":[{"Provided_By__c":"ORPHA:404","HPO_Frequency__c":"Excluded (0%)","Feature__r":{"HPO_Description__c":"A form of primary hyperaldosteronism in which the overproduction of aldosterone can be suppressed by the administration of dexamethasone.","HPO_Feature_URL__c":"https://hpo.jax.org/browse/term/HP:0011739","HPO_Name__c":"Dexamethasone-suppressible primary hyperaldosteronism","Feature_System__c":"Endocrine System","HPO_Feature_Type__c":"Symptom"}},{"Provided_By__c":"ORPHA:404","HPO_Frequency__c":"Frequent (30-79%)","Feature__r":{"HPO_Description__c":"An hormonally active adrenocortical adenoma, that is, an adenoma that secretes excessive amounts of adrenal hormones.","HPO_Feature_URL__c":"https://hpo.jax.org/browse/term/HP:0011746","HPO_Synonym__c":"Secretory adrenal adenoma","HPO_Name__c":"Secretory adrenocortical adenoma","Feature_System__c":"Endocrine System","HPO_Feature_Type__c":"Symptom"}},{"Provided_By__c":"ORPHA:404","HPO_Frequency__c":"Occasional (5-29%)","Feature__r":{"HPO_Description__c":"An abnormally decreased potassium concentration in the blood.","HPO_Feature_URL__c":"https://hpo.jax.org/browse/term/HP:0002900","HPO_Synonym__c":"Low blood potassium levels","HPO_Name__c":"Hypokalemia","HPO_Feature_Type__c":"Lab"}},{"Provided_By__c":"ORPHA:404","HPO_Frequency__c":"Occasional (5-29%)","Feature__r":{"HPO_Description__c":"Reduced strength of muscles.","HPO_Feature_URL__c":"https://hpo.jax.org/browse/term/HP:0001324","HPO_Synonym__c":"Muscle weakness; Muscular weakness","HPO_Name__c":"Muscle weakness","Feature_System__c":"Musculoskeletal System","HPO_Feature_Type__c":"Symptom"}},{"Provided_By__c":"ORPHA:404","HPO_Frequency__c":"Occasional (5-29%)","Feature__r":{"HPO_Description__c":"Metabolic alkalosis is defined as a disease state where the pH is elevated to greater than 7.45 secondary to some metabolic process.","HPO_Feature_URL__c":"https://hpo.jax.org/browse/term/HP:0200114","HPO_Name__c":"Metabolic alkalosis","HPO_Feature_Type__c":"Lab"}},{"Provided_By__c":"ORPHA:404","HPO_Frequency__c":"Occasional (5-29%)","Feature__r":{"HPO_Description__c":"Tinnitus is an auditory perception that can be described as the experience of sound, in the ear or in the head, in the absence of external acoustic stimulation.","HPO_Feature_URL__c":"https://hpo.jax.org/browse/term/HP:0000360","HPO_Synonym__c":"Ringing in ears; Ringing in the ears","HPO_Name__c":"Tinnitus","HPO_Feature_Type__c":"Symptom"}},{"Provided_By__c":"ORPHA:404","HPO_Frequency__c":"Occasional (5-29%)","Feature__r":{"HPO_Description__c":"A sensation of unease in the stomach together with an urge to vomit.","HPO_Feature_URL__c":"https://hpo.jax.org/browse/term/HP:0002018","HPO_Synonym__c":"Nausea","HPO_Name__c":"Nausea","Feature_System__c":"Digestive System","HPO_Feature_Type__c":"Symptom"}},{"Provided_By__c":"ORPHA:404","HPO_Frequency__c":"Occasional (5-29%)","Feature__r":{"HPO_Description__c":"Cephalgia, or pain sensed in various parts of the head, not confined to the area of distribution of any nerve.","HPO_Feature_URL__c":"https://hpo.jax.org/browse/term/HP:0002315","HPO_Synonym__c":"Headache; Headaches","HPO_Name__c":"Headache","Feature_System__c":"Nervous System","HPO_Feature_Type__c":"Symptom"}},{"Provided_By__c":"ORPHA:404","HPO_Frequency__c":"Occasional (5-29%)","Feature__r":{"HPO_Description__c":"Hemorrhage occurring within the skull.","HPO_Feature_URL__c":"https://hpo.jax.org/browse/term/HP:0002170","HPO_Synonym__c":"Bleeding within the skull","HPO_Name__c":"Intracranial hemorrhage","Feature_System__c":"Nervous System; Cardiovascular System; Blood and Blood-Forming Tissue","HPO_Feature_Type__c":"Symptom"}},{"Provided_By__c":"ORPHA:404","HPO_Frequency__c":"Occasional (5-29%)","Feature__r":{"HPO_Description__c":"Enlargement of the adrenal gland.","HPO_Feature_URL__c":"https://hpo.jax.org/browse/term/HP:0008221","HPO_Synonym__c":"Enlarged adrenal glands","HPO_Name__c":"Adrenal hyperplasia","Feature_System__c":"Endocrine System","HPO_Feature_Type__c":"Symptom"}},{"Provided_By__c":"ORPHA:404","HPO_Frequency__c":"Occasional (5-29%)","Feature__r":{"HPO_Description__c":"Epistaxis, or nosebleed, refers to a hemorrhage localized in the nose.","HPO_Feature_URL__c":"https://hpo.jax.org/browse/term/HP:0000421","HPO_Synonym__c":"Bloody nose; Frequent nosebleeds; Nasal hemorrhage; Nose bleed; Nose bleeding; Nosebleed","HPO_Name__c":"Epistaxis","Feature_System__c":"Blood and Blood-Forming Tissue","HPO_Feature_Type__c":"Symptom"}},{"Provided_By__c":"ORPHA:404","HPO_Frequency__c":"Very frequent (80-99%)","Feature__r":{"HPO_Description__c":"A form of primary hyperaldosteronism in which the overproduction of aldosterone cannot be suppressed by the administration of dexamethasone or similar glucocorticoids.","HPO_Feature_URL__c":"https://hpo.jax.org/browse/term/HP:0011740","HPO_Name__c":"Glucocortocoid-insensitive primary hyperaldosteronism","Feature_System__c":"Endocrine System","HPO_Feature_Type__c":"Symptom"}},{"Provided_By__c":"ORPHA:404","HPO_Frequency__c":"Very frequent (80-99%)","Feature__r":{"HPO_Description__c":"A deviation from the normal concentration of renin in the blood, a central hormone in the control of blood pressure and various other physiological functions.","HPO_Feature_URL__c":"https://hpo.jax.org/browse/term/HP:0040084","HPO_Synonym__c":"Abnormal circulating renin; Abnormal plasma renin","HPO_Name__c":"Abnormal circulating renin concentration","Feature_System__c":"Endocrine System","HPO_Feature_Type__c":"Symptom"}},{"Provided_By__c":"ORPHA:404","HPO_Frequency__c":"Always (100%)","Feature__r":{"HPO_Description__c":"The presence of chronic increased pressure in the systemic arterial system.","HPO_Feature_URL__c":"https://hpo.jax.org/browse/term/HP:0000822","HPO_Synonym__c":"Arterial hypertension; Systemic hypertension","HPO_Name__c":"Hypertension","Feature_System__c":"Cardiovascular System","HPO_Feature_Type__c":"Symptom"}}],"tags":{"Specialist":["Cancer - Oncologist","Genetics","Nephrology","Endocrine"],"Disease Category":["Cancer","Genetics","Nephrology","Endocrine"],"Cause":["Genetics"],"Account":["Nephrology"]},"synonyms":["familial adrenal adenoma"," familial hyperaldosteronism type 2"," fh ii"," fh-ii"," fh2"]}